Skip to main content
SpringerLink
Log in

Hyperhomozysteinämie

  • Chapter
Book cover Medizinische Therapie 2007 | 2008

  • 80 Accesses

Auszug

Seit einigen Jahren gehört die Homozysteinämie zu den Risikofaktoren für atherosklerotische Gefäßerkrankungen und venöse Thromboembolien. Homozystein ist eine schwefelhaltige essentielle Aminosäure und das demethylierte Derivat von Methionin. Verschiedene Regelmechanismen halten seine Konzentration im menschlichen Organismus niedrig.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 39.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274:1049–1057

    Article  PubMed  CAS  Google Scholar 

  • Den Heijer M, Koster T, Blom HJ et al. (1996) Hyperhomocysteinemia as risk factor for deepvein thrombosis. N Engl J Med 334:759–762

    Article  Google Scholar 

  • Graham I, Daly LE, Refsum HM et al. (1997) Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA 277:1775–1781

    Article  PubMed  CAS  Google Scholar 

  • Homocysteine Lowering Trialist Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: metaanalysis of randomised trials. BMJ 316:894–898

    Google Scholar 

  • Stein JH, McBride PE (1998) Hyperhomocysteinemia and atherosclerotic vascular disease. Arch Intern Med 158:1301–1306

    Article  PubMed  CAS  Google Scholar 

  • Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338:1042–1050

    Article  PubMed  CAS  Google Scholar 

  • Wuillemin WA, Solenthaler M (1999) Hyperhomozysteinämie: Risikofaktor für arterielle und venöse thrombotische Erkrankungen. VASA 28:151–155

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Hämatologie, Medizinische Klinik Kantonsspital, CH-6000, Luzern 16

    PD Dr. Dr. Walter A. Wuillemin & Dr. Alan Niederer

Authors
  1. PD Dr. Dr. Walter A. Wuillemin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. Alan Niederer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Innere Medizin I, Klinikum der Universität Regensburg, 93042, Regensburg

    Jürgen Schölmerich

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Wuillemin, W.A., Niederer, A. (2007). Hyperhomozysteinämie. In: Schölmerich, J. (eds) Medizinische Therapie 2007 | 2008. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-48554-4_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-48554-4_38

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-48553-7

  • Online ISBN: 978-3-540-48554-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation